UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming

Nature communications, 2021-01, Vol.12 (1), p.409-18, Article 409

2021

Volltextzugriff (PDF)

Phase I Study of Chimeric Antigen Receptor-Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers

Clinical cancer research, 2018-03, Vol.24 (6), p.1277-1286

2018

Volltextzugriff (PDF)

Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1–2 trial

Leukemia, 2022-01, Vol.36 (1), p.189-196

2022

Volltextzugriff (PDF)

Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment

Protein & cell, 2017-12, Vol.8 (12), p.896-925

2017

Volltextzugriff (PDF)

Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers

Protein & cell, 2018-10, Vol.9 (10), p.838-847

2018

Volltextzugriff (PDF)

Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

Journal of hematology and oncology, 2020-04, Vol.13 (1), p.30-10, Article 30

2020

Volltextzugriff (PDF)

Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer

Science China. Life sciences, 2016-05, Vol.59 (5), p.468-479

2016

Volltextzugriff (PDF)

Clinical development of CAR T cell therapy in China: 2020 update

Cellular & molecular immunology, 2021-04, Vol.18 (4), p.792-804

2021

Volltextzugriff (PDF)

Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial

Oncoimmunology, 2020-01, Vol.9 (1), p.1846926-1846926

2020

Volltextzugriff (PDF)

CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial

Oncoimmunology, 2018-07, Vol.7 (7), p.e1440169-e1440169

2018

Volltextzugriff (PDF)

Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment

Protein & cell, 2018-06, Vol.9 (6), p.516-526

2018

Volltextzugriff (PDF)

Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats

Diabetes (New York, N.Y.), 2012-06, Vol.61 (6), p.1616-1625

2012

Volltextzugriff (PDF)

Cytokine‐induced killer (CIK) cells: from basic research to clinical translation

Ai zheng, 2015-03, Vol.34 (3), p.1-9, Article 6

2015

Volltextzugriff (PDF)

Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity

Diabetes (New York, N.Y.), 2012-06, Vol.61 (6), p.1616-1625

2012

Volltextzugriff (PDF)

Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies

Signal transduction and targeted therapy, 2022-04, Vol.7 (1), p.98-98, Article 98

2022

Volltextzugriff (PDF)

Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment

Cellular & molecular immunology, 2020-04, Vol.17 (4), p.430-432

2020

Volltextzugriff (PDF)

Reciprocal activation of antigen-presenting cells and CAR T cells triggers a widespread endogenous anti-tumor immune response through sustained high-level IFNγ production

Cancer biology & medicine, 2023-11, Vol.20 (11), p.1-4

2023

Volltextzugriff (PDF)

PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity

Journal for immunotherapy of cancer, 2019-08, Vol.7 (1), p.209-209, Article 209

2019

Volltextzugriff (PDF)

Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo

Protein & cell, 2018-10, Vol.9 (10), p.867-878

2018

Volltextzugriff (PDF)

Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects

Journal of Immunology Research, 2016-01, Vol.2016 (2016), p.1-11

2016

Volltextzugriff (PDF)

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

Oncoimmunology, 2015-11, Vol.4 (11), p.e1027469-e1027469

2015

Volltextzugriff (PDF)

Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation

Journal of hematology and oncology, 2019-06, Vol.12 (1), p.57-57, Article 57

2019

Volltextzugriff (PDF)

Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma

Signal transduction and targeted therapy, 2023-10, Vol.8 (1), p.409-409, Article 409

2023

Volltextzugriff (PDF)

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia

Journal of hematology and oncology, 2016-11, Vol.9 (1), p.131-131, Article 131

2016

Volltextzugriff (PDF)

Beta-cell regeneration from vimentin+/MafB+ cells after STZ-induced extreme beta-cell ablation

Scientific reports, 2015-07, Vol.5 (1), p.11703, Article 11703

2015

Volltextzugriff (PDF)

1 – 25 von 124

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(108)

Publikationsform

Sprache

Englisch
(119)
Chinesisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(85)
Technology
(43)
Engineering
(38)
Life Sciences & Biomedicine
(37)
Engineering, Electrical & Electronic
(36)
Physical Sciences
(32)
Physics
(30)
Physics, Applied
(27)
Traveling Wave Tubes
(23)
Humans
(21)
Traveling Waves
(21)
Electron Beams
(15)
Lymphocytes T
(15)
Antigens
(13)
Bandwidth
(13)
Immunotherapy
(13)
Oncology
(13)
Chimeric Antigen Receptors
(12)
Female
(12)
Gyrotrons
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogramming

Phase I Study of Chimeric Antigen Receptor-Modified T Cells in Patients with EGFR-Positive Advanced Biliary Tract Cancers

Long-term activity of tandem CD19/CD20 CAR therapy in refractory/relapsed B-cell lymphoma: a single-arm, phase 1–2 trial

Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment

Phase I study of chimeric antigen receptor modified T cells in treating HER2-positive advanced biliary tract cancers and pancreatic cancers

Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemia

Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer

Clinical development of CAR T cell therapy in China: 2020 update

Efficacy and biomarker analysis of CD133-directed CAR T cells in advanced hepatocellular carcinoma: a single-arm, open-label, phase II trial

CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial

Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment

Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats

Cytokine‐induced killer (CIK) cells: from basic research to clinical translation

Infusion of Mesenchymal Stem Cells Ameliorates Hyperglycemia in Type 2 Diabetic Rats: Identification of a Novel Role in Improving Insulin Sensitivity

Identification of NOXA as a pivotal regulator of resistance to CAR T-cell therapy in B-cell malignancies

Efficiency and side effects of anti-CD38 CAR T cells in an adult patient with relapsed B-ALL after failure of bi-specific CD19/CD22 CAR T cell treatment

Reciprocal activation of antigen-presenting cells and CAR T cells triggers a widespread endogenous anti-tumor immune response through sustained high-level IFNγ production

PD-1 silencing impairs the anti-tumor function of chimeric antigen receptor modified T cells by inhibiting proliferation activity

Effective and persistent antitumor activity of HER2-directed CAR-T cells against gastric cancer cells in vitro and xenotransplanted tumors in vivo

Chimeric Antigen Receptor-Modified T Cells for Solid Tumors: Challenges and Prospects

Tolerance and efficacy of autologous or donor-derived T cells expressing CD19 chimeric antigen receptors in adult B-ALL with extramedullary leukemia

Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantation

Characteristics of premanufacture CD8+ T cells determine CAR-T efficacy in patients with diffuse large B-cell lymphoma

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia

Beta-cell regeneration from vimentin+/MafB+ cells after STZ-induced extreme beta-cell ablation

Suchergebnisse filtern